CLINICAL_TRIALS
trial_result
· 2011-01-04
Clinical Trial Update: Study Evaluating The Efficacy And Safety Of Xyntha In Children Less Than 6 Years Of Age [Phase 3]
Summary
Phase 3 trial evaluating Xyntha in children under 6 with Hemophilia A was terminated; results posted in 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Hemophilia A | Phase 3 | Status: TERMINATED | Results posted: 2011-01-04